Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPISO
2024-516074-29-00Phase 3Withdrawn
- Sponsor
- University Hospital Odense
- Start
- Feb 2025
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in cardiac arrest (SCA) comparing Epinephrine arm with Isoprenaline arm (2 arms). Primary endpoint: Sustained return of spontaneous circulation. Planned start Feb 2025; status: withdrawn.
02
Drugs
epinephrineisoprenaline
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on 2024-516074-29-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516074-29-00.